Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences

Rhea-AI Summary

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will participate in two upcoming investor conferences. The Cowen 42nd Annual Health Care Conference is scheduled for March 7, 2022, from 2:10 - 2:40 p.m. ET. The Needham Virtual Neuroscience Forum will take place on March 16, 2022, from 1:05 - 1:45 p.m. ET. Webcasts of both presentations will be accessible via the Jazz Pharmaceuticals website for 30 days following the events. Jazz is dedicated to developing innovative therapies for serious diseases.

DUBLIN, Feb. 28, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following upcoming virtual investor conferences:

Cowen 42^nd Annual Health Care Conference on Monday, March 7, 2022

• The presentation is scheduled for 2:10 – 2:40 p.m. ET / 7:10 – 7:40 p.m. GMT

Needham Virtual Neuroscience Forum on Wednesday, March 16, 2022

• The presentation is scheduled for 1:05 – 1:45 p.m. ET / 6:05 – 6:45 p.m. GMT

Webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharma.com. Replays of the webcasts will be available on the website for 30 days.  

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharma.com and follow @JazzPharma on Twitter.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-march-investor-conferences-301491723.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When is Jazz Pharmaceuticals participating in the Cowen Health Care Conference?

Jazz Pharmaceuticals will present at the Cowen 42nd Annual Health Care Conference on March 7, 2022, from 2:10 - 2:40 p.m. ET.

What is the schedule for the Needham Virtual Neuroscience Forum featuring Jazz Pharmaceuticals?

The Needham Virtual Neuroscience Forum with Jazz Pharmaceuticals is on March 16, 2022, from 1:05 - 1:45 p.m. ET.

Where can I watch the Jazz Pharmaceuticals investor conference presentations?

The presentations by Jazz Pharmaceuticals will be webcasts available on their website for 30 days after the conferences.

What is the focus of Jazz Pharmaceuticals as a biopharmaceutical company?

Jazz Pharmaceuticals focuses on developing life-changing medicines for serious diseases with limited therapeutic options.